Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma
- 1 August 1996
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 74 (3) , 339-341
- https://doi.org/10.1038/bjc.1996.363
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.Journal of Medical Genetics, 1995
- Mutagenic analysis of functional domains of the mos proto-oncogene and identification of the sites important for MAPK activation and DNA binding.1995
- Genotype‐phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation ConsortiumJournal of Internal Medicine, 1995
- Analysis ofRET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomasCancer, 1995
- Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung diseaseHuman Molecular Genetics, 1995
- RET mutations in exons 13 and 14 of FMTC patients.1995
- Mutations in the RET protooncogene in sporadic pheochromocytomas.Journal of Clinical Endocrinology & Metabolism, 1995
- Pheochromocytomas and C-cell thyroid neoplasms in transgenic c-mos mice: a model for the human multiple endocrine neoplasia type 2 syndrome.1992
- Function of c-mos proto-oncogene product in meiotic maturation in Xenopus oocytesNature, 1988
- Deletion of genes on chromosome 1 in endocrine neoplasiaNature, 1987